Resalis Therapeutics Reports RES-010 First-in-Human Safety Data
Resalis Therapeutics announced first-in-human data for RES-010, reporting safety and tolerability. The headline also notes early weight-loss signals.
Story updates
10:01:24 AM UTC
SquawkNews
The completed Phase 1a study data in healthy volunteers showed early signs of pharmacodynamic activi